Chan Zuckerberg Initiative

Science Diversity Leadership Award LOI

November 6, 2024

The Chan Zuckerberg Initiative invites applications for a five-year funding grant (2025–2030) that supports excellent biomedical researchers with a record of promoting diversity, equity, and inclusion in their scientific field.

Opportunity: Science Diversity Leadership Award LOI
Deadline: 12/3/2024
Funding: $1,150,000 over five years


Eligibility:

  • Applicants must hold an MD, PhD, ScD, MD/PhD, DDM, DVM, or equivalent degree and have a faculty position or equivalent independent investigator status at a college, university, medical school, or other research facility. Note that non-tenured and tenured faculty are eligible to apply.
  • Applicants should have been in their first independent position for at least three years and less than ten years as of the opening of the Letter of Intent application.
  • Applications must be submitted by US nonprofit organizations, including public and private institutions, such as colleges, universities, hospitals, laboratories, and governmental agencies. For-profit organizations are not eligible to apply. All grants will be awarded to institutions, not individuals.
  • An organization may submit more than one application.
  • Current or former Science Diversity Leadership grantees are not eligible for this RFA.
  • Meta employees, including employees of any subsidiary Meta entities and employees of Chan Zuckerberg Initiative, LLC, are not permitted to apply.

Overview: The Science Diversity Leadership Award (SDLA) from the Chan Zuckerberg Initiative (CZI) will support Principal Investigators who are outstanding early- to mid-career biomedical researchers at U.S. universities, medical schools, or nonprofit research institutes who—through their outreach, mentoring, teaching, and leadership—have a record of promoting diversity, equity, and inclusion (DEI) in their scientific communities. They will have made significant research contributions to the biomedical sciences, show promise for continuing scientific achievement, and demonstrate leadership in efforts to diversify the sciences. CZI is committed to supporting representative science, which ensures universal benefits from scientific advances, such as studies of diseases that adversely affect underserved populations from specific ancestries, and promotes diversity among researchers toward more inclusive and comprehensive outcomes.Applicants will perform research related broadly to biomedical sciences. Preference will be given to research programs that align with CZI Science and/or programs with diversity as a research component. Part of the applicant's evaluation will include their research contributions and current research program. Note: Clinical trials and public health research are out of scope for this award.

 

Learn More